Gunderson Dettmer advised Immunitas Therapeutics in the transaction. The round was led by Leaps by Bayer and Novartis Venture Fund with participation from Evotec, M Ventures,…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now